NASDAQ · IVF

INVO Fertility, Inc.

$1.00 -$0.02 (-1.96%) 1D After hours
Session Pulse Overnight session 1 mentions on Fri No new SEC filings since Mon close its sector ranked 6/11 this week Full pulse →

Key Metrics

$1.82M
Market cap
0.15×
P/E · TTM
$378.04K
Revenue · TTM
$11.86M
Net income
EPS · TTM $2,368.11
Dividend yield
Free cash flow
Beta · 1Y 1.25
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - INVO Fertility, Inc. (0001417926) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 24
    From its Jan 29 high, the share price fell 86%.

    Peak close $7.05 on Jan 29; trough close $1.00 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -86%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    The stock moved +97.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 26
  • Jun 1
    The stock moved -21.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.82M
Enterprise value
Shares outstanding1.8M
52-wk range$0.28 – $22.90
Avg volume · 20D2.3M
Net cash
Book value / share$2,998.73
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About INVO Fertility, Inc.
IPO dateNov 11, 2008
Employees46

INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell).

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E0.15
P/S4.82
P/FCF
EV/EBITDA
EV/Sales
Graham №$12,640.41

Profitability

Gross
Operating 4,104.4%
Net 3,138.4%
FCF
ROE / ROIC 79.0% · —

Financial Health

Current ratio0.90
Quick ratio0.87
Debt / equity0.13
Debt / EBITDA
Net cash
Working capital−$621.68K

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-3.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$12,640.41 vs $1.00
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings